Unichem Laboratories Ltd

Unichem Laboratories Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 16 February 2026, reflecting a change in the company’s assessment. However, all fundamentals, returns, and financial metrics discussed below are current as of 23 March 2026, providing investors with an up-to-date view of the stock’s position.

Unichem Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Unichem Laboratories Ltd’s share price declined to a fresh 52-week low of Rs.304.25 today, marking a significant downturn amid broader market gains. The stock has underperformed its sector and key indices, reflecting ongoing pressures on the company’s financial and market performance.

Unichem Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Unichem Laboratories Ltd’s shares declined sharply to a new 52-week low of Rs.309.4 on 9 March 2026, marking a significant downturn amid broader market weakness and company-specific headwinds. The stock underperformed its sector and key indices, reflecting ongoing concerns about its financial health and recent quarterly results.

Unichem Laboratories Ltd’s shares declined to a fresh 52-week low of Rs.315.6 on 4 Mar 2026, marking a significant milestone in a sustained downward trajectory. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial and operational metrics.

Unichem Laboratories Ltd’s stock reached a fresh 52-week low of Rs.324.6 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing concerns about its financial metrics and recent quarterly results.

Unichem Laboratories Ltd witnessed a weak start to the trading session on 2 Mar 2026, opening with a significant gap down of 6.51%, reflecting heightened market concerns following recent developments. The stock hit a new 52-week low of Rs.324.6, continuing its downward trajectory amid elevated volatility and sector pressures.

Unichem Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Unichem Laboratories Ltd’s shares declined to a fresh 52-week low of Rs.344.85 on 27 Feb 2026, marking a significant downturn amid broader market weakness. The stock has underperformed its sector and benchmark indices, reflecting ongoing concerns about its financial metrics and recent quarterly results.

Unichem Laboratories Ltd’s shares declined sharply to a new 52-week low of Rs.345.2 on 26 Feb 2026, marking a significant drop amid broader market fluctuations. The stock underperformed its sector and key benchmarks, reflecting ongoing concerns about the company’s financial metrics and recent quarterly results.

Unichem Laboratories Ltd’s share price declined to a fresh 52-week low of Rs.350.45 today, marking a significant downturn amid broader market fluctuations and company-specific performance concerns. The stock has underperformed its sector and benchmark indices, reflecting ongoing challenges in financial metrics and recent quarterly results.

Unichem Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a very attractive rating, despite ongoing sector headwinds and a challenging market environment. This change reflects a significant reappraisal of the company’s price-to-earnings and price-to-book value metrics relative to its historical averages and peer group, offering investors a fresh perspective on its price attractiveness.

Unichem Laboratories Ltd’s shares declined sharply today, hitting a new 52-week low of Rs.352.6. This marks a significant drop amid broader market gains, with the stock underperforming its sector and key moving averages.

Unichem Laboratories Ltd has reached a new 52-week low of Rs.360.55, marking a significant decline in its stock price amid ongoing downward momentum. The pharmaceutical company’s shares have underperformed both its sector and the broader market, reflecting a series of financial and performance concerns.

Unichem Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a significant improvement in its valuation metrics. Despite ongoing financial headwinds and subdued operational performance, the company’s attractive valuation relative to peers has prompted a reassessment of its investment appeal.